Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

British Journal of Cancer

Volumn 77, Issue 12, 1998, Pages 2193-2198

  Bartlett, J M S ^a   Watters, A D ^a   Ballantyne, S A ^a   Going, J J ^a   Grigor, K M ^a   Cooke, T G ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bladder; Chromosome 9; Diagnostic; Fluorescence in situ hybridization; Monosomy; Pathology; Quantitation; Recurrence; Survival; Transitional cell carcinoma

Indexed keywords

SATELLITE DNA;

ARTICLE; BLADDER CARCINOMA; BLADDER EPITHELIUM; CANCER RECURRENCE; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME 9Q; CHROMOSOME LOSS; CONTROLLED STUDY; EPIDERMIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOSOMY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0031777591     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.365     Document Type: Article

References (22)